Goldman Sachs’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,256
Closed -$637K – 6924
2026
Q1
$637K Buy
+22,256
New +$648K ﹤0.01% 5432

Other funds holding REVS

Goldman Sachs's REVS Position: Q2 2026 in Review

Goldman Sachs sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 22,256 shares — an estimated $637K sold.

Goldman Sachs first reported a position in REVS in Q1 2026 and held it in 1 quarter. The position peaked at $637K in Q1 2026. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Goldman Sachs reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 22,256 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $637K.
  • Goldman Sachs first reported a position in Columbia Research Enhanced Value ETF in Q1 2026 and held it in 1 quarter.
  • Goldman Sachs's Columbia Research Enhanced Value ETF position peaked at $637K in Q1 2026.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.